-

Humana Announces Plan for CFO Transition

LOUISVILLE, Ky.--(BUSINESS WIRE)--Humana Inc. (NYSE: HUM) announced today that Brian Kane will be transitioning from his role as Chief Financial Officer to pursue broader career goals. To ensure a smooth transition, Kane has agreed to remain in his current role through June 1, 2021, and then serve in an advisory role through the end of the year.

Susan Diamond, Segment President for Humana’s Home Business, will assume the role of interim CFO, effective June 1, while the Company completes its search for a permanent replacement. Diamond will continue leading the Home business.

“We sincerely thank Brian for his invaluable contributions to Humana over the years,” said Bruce D. Broussard, Humana’s President and Chief Executive Officer. “He has been an instrumental member of the leadership team, helping to formulate and drive the Company’s strategy and create significant shareholder value over his seven-year career with Humana. In addition to exhibiting strong financial acumen as CFO, Brian has had direct oversight of the Company’s care delivery organization, which has seen a meaningful turnaround at Conviva Care Solutions and significant innovation and organic growth at Partners in Primary Care. Today, combined operations include 170 senior-focused clinics serving more than 250,000 patients with approximately $2.5 billion in revenue, one of the largest organizations of its kind in the nation.”

“Among his many contributions, Brian brought rigor to his role and the creation of a strong financial capability—not only through sophisticated fiscal and ongoing operational discipline, but also by developing a deep bench of talent within our finance organization to drive this discipline forward. We wish Brian the very best in his next chapter,” said Broussard.

Speaking to the transition plans, Kane said, “I’m proud of what Humana has accomplished in a period of rapid transformation. I know that under Bruce’s leadership and with support of the outstanding team across the organization, the Company is well positioned to continue executing on its strategic plans and delivering shareholder value in the coming years. It’s been an honor to serve the members of Humana, and I am grateful to have worked with so many talented colleagues. I am fully committed to a seamless transition in the coming months.”

“Although we will miss Brian, I am excited about and personally committed to seeing our strategy through to fruition in the coming years,” said Broussard. “Given Susan’s strong knowledge of our business and financial expertise, I have great confidence in her ability to lead the finance team as we recruit a new CFO.”

Diamond joined Humana in 2006 and has held various leadership roles across the Company during her tenure. She spent eight years as part of the Medicare leadership team, with various financial, operational and line of business responsibilities and two years on Kane’s leadership team responsible for enterprise planning and forecasting as well as oversight of the Company’s lines of business CFOs and controllers. Before joining Humana, Diamond served as CFO for Smoothstone IP Communications and Prosperitas Investment Partners. She began her career with PricewaterhouseCoopers and holds a Bachelor’s Degree in Accounting from Bellarmine University (formerly College).

The Company has commenced a search with the assistance of a leading search firm for the next CFO. A new Office of the CFO comprised of Diamond and other members of Humana’s management and finance team is being established to ensure continued financial discipline and stewardship of Humana’s growth story.

About Humana

Humana Inc. (NYSE: HUM) is committed to helping our millions of medical and specialty members achieve their best health. Our successful history in care delivery and health plan administration is helping us create a new kind of integrated care with the power to improve health and well-being and lower costs. Our efforts are leading to a better quality of life for people with Medicare, families, individuals, military service personnel, and communities at large.

To accomplish that, we support physicians and other health care professionals as they work to deliver the right care in the right place for their patients, our members. Our range of clinical capabilities, resources and tools – such as in-home care, behavioral health, pharmacy services, data analytics and wellness solutions – combine to produce a simplified experience that makes health care easier to navigate and more effective.

More information regarding Humana is available to investors via the Investor Relations page of the company’s website at humana.com, including copies of:

  • Annual reports to stockholders
  • Securities and Exchange Commission filings
  • Most recent investor conference presentations
  • Quarterly earnings news releases and conference calls
  • Calendar of events
  • Corporate Governance information

 

Contacts

Amy Smith
Investor Relations
Humana Inc.
502-580-2811
amysmith@humana.com
or
Kelley Murphy
Corporate Communications
Humana Inc.
502-224-1755
kmurphy26@humana.com

Humana Inc.

NYSE:HUM

Release Versions

Contacts

Amy Smith
Investor Relations
Humana Inc.
502-580-2811
amysmith@humana.com
or
Kelley Murphy
Corporate Communications
Humana Inc.
502-224-1755
kmurphy26@humana.com

More News From Humana Inc.

Humana Announces Insurance Leadership Transition

LOUISVILLE, Ky.--(BUSINESS WIRE)--Humana Inc. (NYSE: HUM) today announced that George Renaudin, Insurance Segment President and member of Humana’s Enterprise Leadership Team, will retire by Q3 2026 following a successful 29-year career at the company. During this period, Renaudin played a pivotal role in establishing and growing Humana’s Medicare Advantage and Medicaid programs, helping to build them into high-performing businesses and assembling a strong insurance leadership team. “George has...

Humana Inc. to Present at 2025 Wolfe Research Healthcare Conference

LOUISVILLE, Ky.--(BUSINESS WIRE)--Humana Inc. (NYSE: HUM) announced today that Celeste Mellet, Chief Financial Officer, will make a presentation to investors at the Wolfe Research Healthcare Conference on Wednesday, November 19, 2025, at 8:40 a.m. Eastern time. A live audio webcast of the presentation will be available via Humana’s Investor Relations page at https://humana.gcs-web.com/. The company suggests webcast participants sign on approximately 15 minutes in advance of the presentation to...

Humana Reports Third Quarter 2025 Financial Results; Affirms Full Year 2025 Adjusted EPS Guidance

LOUISVILLE, Ky.--(BUSINESS WIRE)--Humana Inc. (NYSE: HUM) today reported consolidated pretax results and diluted earnings per share (EPS) for the quarter ended September 30, 2025 (3Q25) versus the quarter ended September 30, 2024 (3Q24) and for the nine months ended September 30, 2025 (YTD 2025) versus the nine months ended September 30, 2024 (YTD 2024) as noted in the tables below. Consolidated income before income taxes and equity in net losses (pretax results) in millions 3Q25 (a) 3Q24 (a) Y...
Back to Newsroom